Acticor Biotech Overview

  • Founded
  • 2013
Founded
  • Status
  • IPO Registration
  • Employees
  • 20
Employees
  • Latest Deal Type
  • IPO
  • Latest Deal Amount
  • $18M
Latest Deal Amount
  • Investors
  • 14

Acticor Biotech General Information

Description

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Hôpital Bichat-Inserm U1148
  • 46, rue Henri Huchard, Cedex 18
  • 75018 Paris
  • France
+33 09 00 00 00 00

Acticor Biotech Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Acticor Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 01-Nov-2021 $18M 000.00 000.00 Completed Clinical Trials - Phase 3
6. Later Stage VC 07-Sep-2021 00.000 000.00 000.00 Completed Clinical Trials - Phase 3
5. Later Stage VC (Series B) 06-Nov-2019 000.00 000.00 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC 20-Dec-2017 00.000 00.000 000.00 Completed Pre-Clinical Trials
3. Later Stage VC 07-Feb-2017 00.000 00.000 00.000 Completed Pre-Clinical Trials
2. Seed Round 26-Jan-2015 $782K $782K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Acticor Biotech’s complete valuation and funding history, request access »

Acticor Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preference 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preference 00,000 00.000000 000.00 000.00 00 000.00 0.000
Preference 28,039 $1.177398 $64.76 $64.76 1x $64.76 6.7%
Ordinary 17,552 $1.177398 $44.74 $44.74 1x $44.74 4.2%
To view Acticor Biotech’s complete cap table history, request access »

Acticor Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emerge
Biotechnology
Paris, France
20 As of 2021
000.00
00.00 0000-00-00
00000000 000.00

00000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non p
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

0000000

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000 000000000
Portland, OR
0 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acticor Biotech Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 Accelerator/Incubator Backed Portland, OR 0 0000000000
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000 00000000000 Private Equity-Backed Cambridge, MA 00 00000 0000000000 0 00000
You’re viewing 5 of 18 competitors. Get the full list »

Acticor Biotech Patents

Acticor Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018214222-B2 Inhibition of platelet aggregation using anti-human gpvi antibodies Active 03-Feb-2017 00000000000 0
JP-2020507317-A Inhibition of platelet aggregation using anti-human gpvi antibody Pending 03-Feb-2017 00000000000
US-20190367608-A1 Inhibition of platelet aggregation using anti-human gpvi antibodies Pending 03-Feb-2017 00000000000
CA-3051169-A1 Inhibition of platelet aggregation using anti-human gpvi antibodies Pending 03-Feb-2017 00000000000
AU-2018214222-C1 Inhibition of platelet aggregation using anti-human gpvi antibodies Active 03-Feb-2017 C07K16/2803 0
To view Acticor Biotech’s complete patent history, request access »

Acticor Biotech Executive Team (10)

Name Title Board Seat Contact Info
Gilles Avenard MD Co-Founder, President, Chief Executive Officer & Chairman
Eric Cohen Chief Financial Officer
Sophie Lebel-Binay Ph.D General Manager, Scientific Director, Chief Scientific & Operating Officer
Yannick Plétan MD Chief Medical Officer & General Manager
Philippe Billiald Ph.D Co-Founder & Scientific Advisor
You’re viewing 5 of 10 executive team members. Get the full list »

Acticor Biotech Board Members (13)

Name Representing Role Since
Alain Munoz MD Self Chairman 000 0000
Alain Parthoens Self Board Observer 000 0000
Catherine Boule Karista (France) Board Member 000 0000
Gilles Avenard MD Acticor Biotech Co-Founder, President, Chief Executive Officer & Chairman 000 0000
Guy Heynen MD Newton BioCapital Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Acticor Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acticor Biotech Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
A&B (HK) Company Corporation Minority 000 0000 000000 0
ANAXAGO Real Estate Minority 000 0000 000000 0
Antoine Lindrec Angel (individual) Minority 000 0000 000000 0
China Medical System Corporation Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Acticor Biotech Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 06-Nov-2019 0000000000 Diagnostic Equipment 000000 00
To view Acticor Biotech’s complete acquisitions history, request access »